title: (18)F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617.
authors.affiliation: Department for Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.
authors.forename: Frederik L
authors.initials: FL
authors.lastname: Giesel
authors.affiliation: Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
authors.forename: Jens
authors.initials: J
authors.lastname: Cardinale
authors.affiliation: Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Schäfer
authors.affiliation: Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
authors.forename: Oliver
authors.initials: O
authors.lastname: Neels
authors.affiliation: Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
authors.forename: Martina
authors.initials: M
authors.lastname: Benešová
authors.affiliation: Department for Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.
authors.forename: Walter
authors.initials: W
authors.lastname: Mier
authors.affiliation: Department for Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany.
authors.forename: Uwe
authors.initials: U
authors.lastname: Haberkorn
authors.affiliation: Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
authors.forename: Klaus
authors.initials: K
authors.lastname: Kopka
authors.affiliation: Department for Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120, Heidelberg, Germany. clemens.kratochwil@med.uni-heidelberg.de.
authors.forename: Clemens
authors.identifier: http://orcid.org/0000-0003-1334-8260
authors.initials: C
authors.lastname: Kratochwil
mesh_terms: D004151:Dipeptides / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005462:Fluorine Radioisotopes / Q000627:therapeutic use; D006573:Heterocyclic Compounds, 1-Ring / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009928:Organ Specificity; D017430:Prostate-Specific Antigen; D064129:Prostatic Neoplasms, Castration-Resistant / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000532:radiotherapy*; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D000068936:Theranostic Nanomedicine / Q000379:methods*; D014018:Tissue Distribution; D016896:Treatment Outcome
chemical_list: D004151:Dipeptides; D005462:Fluorine Radioisotopes; D006573:Heterocyclic Compounds, 1-Ring; C000602389:PSMA-617; D019275:Radiopharmaceuticals; D017430:Prostate-Specific Antigen